Abstract: ClinicalTrials.gov NCT00083369 ; May 21, 2004. Researchers analyzed the plasma lipidome of 980 individuals (ages 18–87) to map blood lipid changes across the lifespan. The study identifies significant sex-specific trajectories in lipid profiles, with women exhibiting steeper age-related increases in lipids associated with cardiovascular risk, potentially linked to post-menopausal hormonal shifts.
Introduction
Aging remains the primary risk factor for chronic conditions such as cardiovascular disease (CVD) and neurodegenerative disorders. Lipids, serving as both structural components and signaling molecules, are central to these pathologies. Despite their importance, a comprehensive understanding of how the human "lipidome"—the totality of lipids in the blood—evolves across a normal lifespan has been lacking.
Previous research often relied on serum samples, where clotting can degrade lipid species, or included participants on lipid-lowering medications that obscure natural biological associations. This study establishes a baseline using plasma from a large cohort following a supervised medication washout period to establish how age and sex independently and interactively influence lipid profiles.
Methods
The study utilized data from the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN) cohort.
- Participants: 980 individuals (467 male, 513 female) aged 18–87, primarily of European ancestry.
- Protocol: Participants underwent a four-week washout period from lipid-altering drugs and supplements (e.g., fish oil) prior to blood collection.
- Analytical Technique: Untargeted lipidomic profiling was performed using Liquid Chromatography-Mass Spectrometry (LC-MS/MS), identifying 413 unique lipid species across 15 subclasses.
- Data Processing: Systematic Error Removal using Random Forest (SERRF) was employed to correct for batch effects and day-to-day variation.
- Statistical Analysis: Linear regression models adjusted for BMI examined associations between age, sex, and lipid levels. Crucially, an interaction term (age*sex) was included to identify if the rate of change with age differs between the sexes.
Results
The analysis revealed that aging is not a gender-neutral process regarding lipid metabolism. Significant associations with age were found for 147 lipid species, while 248 species showed baseline differences between sexes. Generally, women had higher total intensities of glycerophospholipids, sphingolipids, and sterol lipids.
Sex-Specific Aging Trajectories
A key finding was the divergence in lipid trajectories between men and women. For 97 individual lipid species, the rate of change with age differed significantly by sex. Women generally exhibited a much steeper increase in lipid levels as they aged, particularly within the glycerophospholipid and glycerolipid classes.
Quantitatively, for every ten-year increase in age, the total intensity of glycerophospholipids was predicted to increase by 0.15 standard deviations in women, compared to only 0.05 standard deviations in men. Similar interaction effects were most prevalent in phosphatidylcholines (PC), sphingomyelins (SM), and triglycerides (TG).
Lipoprotein Particle Size
Lipoprotein profiles also showed divergent trends. Very-low-density lipoprotein (VLDL) particle size, a marker for cardiovascular risk, showed opposite trends: it decreased by an average of 0.090 nm per year in men but increased by 0.036 nm per year in women.
Discussion and Limitations
The steeper lipid increases observed in aging women may be linked to the loss of estrogen signaling during menopause, which typically helps regulate lipid metabolism. These findings suggest that specific lipid species could serve as refined biomarkers for tracking cardiovascular risk specifically in aging women.
Limitations
The study's primary limitation is its lack of diversity, as the GOLDN cohort is 99.9% white, potentially limiting generalizability to other racial or ethnic groups. Additionally, the cross-sectional design provides a "snapshot" rather than longitudinal confirmation of individual trajectories. Future research should integrate direct hormonal data and correlate these sex-specific lipid phenotypes with clinical outcomes like myocardial infarction or stroke to validate their use as clinical biomarkers.
Summary updated